ScienceDaily (Mar. 9, 2009) — A study published online in the Archives of Neurology involving two common drugs used to treat early-stage Parkinson’s disease shows that, while the drugs each have advantages and disadvantages, the overall impact tends to even out over a long period of treatment.
